Location History:
- Halle/Saale, DE (2017 - 2019)
- Halle, DE (2017 - 2020)
Company Filing History:
2 out of 815 
1 out of 148 
1 out of 24 
Years Active: 2017-2020
Title: Bernhard Janowski: Innovator in Biopharmaceutical Purification
Introduction
Bernhard Janowski is a notable inventor based in Halle, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of proteins. With a total of 4 patents to his name, Janowski's work has advanced the methods used in the production of critical therapeutic proteins.
Latest Patents
Janowski's latest patents include a method for the purification of granulocyte-colony stimulating factor (G-CSF). This invention involves a sophisticated process that utilizes cation exchange chromatography and hydrophobic interaction chromatography to effectively purify G-CSF from a mixture of proteins. Another significant patent focuses on proNGF mutants and their applications in producing human beta-NGF. This method outlines the preparation of biologically active human beta-NGF from an inactive proNGF mutant, showcasing Janowski's innovative approach to protein engineering.
Career Highlights
Throughout his career, Janowski has worked with prominent companies such as Wacker Chemie AG and Sandoz AG. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical development and protein purification techniques.
Collaborations
Janowski has collaborated with esteemed colleagues, including Arndt Dietrich and Jörg Schäffner. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Bernhard Janowski's contributions to the field of biopharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in protein purification. His work continues to influence the development of therapeutic proteins, making a significant impact in the industry.